Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Hypertriglyceridemic waist is associated with impaired glucose tolerance in polycystic ovary syndrome.

Lerchbaum E, Schwetz V, Giuliani A, Obermayer-Pietsch B.

Nutr Metab Cardiovasc Dis. 2013 Feb;23(2):e15-6. doi: 10.1016/j.numecd.2012.11.004. Epub 2012 Dec 4. No abstract available.

PMID:
23218173
2.

The "hypertriglyceridemic waist" phenotype and glucose intolerance in pregnancy.

Brisson D, Perron P, Guay SP, Gaudet D, Bouchard L.

CMAJ. 2010 Oct 19;182(15):E722-5. doi: 10.1503/cmaj.100378. Epub 2010 Sep 20.

3.

Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome.

Liang SJ, Liou TH, Lin HW, Hsu CS, Tzeng CR, Hsu MI.

Acta Obstet Gynecol Scand. 2012 Oct;91(10):1167-72. doi: 10.1111/j.1600-0412.2012.01417.x. Epub 2012 Aug 13.

PMID:
22497305
4.

Assessing impaired glucose tolerance and insulin resistance in polycystic ovarian syndrome with a muffin test: an alternative to the glucose tolerance test.

Freeman R, Pollack R, Rosenbloom E.

Endocr Pract. 2010 Sep-Oct;16(5):810-7. doi: 10.4158/EP09330.OR.

PMID:
20439247
5.

Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome.

Xiang S, Hua F, Chen L, Tang Y, Jiang X, Liu Z.

Exp Clin Endocrinol Diabetes. 2013 Feb;121(2):115-8. doi: 10.1055/s-0032-1333261. Epub 2013 Feb 20.

PMID:
23426706
6.

Abdominal obesity and subclinical vascular damage in the elderly.

Fantin F, Di Francesco V, Rossi A, Giuliano K, Marino F, Cazzadori M, Gozzoli MP, Vivian ME, Bosello O, Rajkumar C, Zamboni M.

J Hypertens. 2010 Feb;28(2):333-9. doi: 10.1097/HJH.0b013e328333d23c.

PMID:
19881388
7.

Metabolic screening in patients with polycystic ovary syndrome is largely underutilized among obstetrician-gynecologists.

Dhesi AS, Murtough KL, Lim JK, Schulkin J, McGovern PG, Power ML, Morelli SS.

Am J Obstet Gynecol. 2016 Nov;215(5):579.e1-579.e5. doi: 10.1016/j.ajog.2016.07.043. Epub 2016 Jul 25.

PMID:
27457114
8.

Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome.

Oh JY, Sung YA, Lee HJ, Oh JY, Chung HW, Park H.

Obesity (Silver Spring). 2010 Mar;18(3):593-7. doi: 10.1038/oby.2009.297. Epub 2009 Sep 17.

9.

Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome.

Pesant MH, Baillargeon JP.

Fertil Steril. 2011 Jan;95(1):210-5. doi: 10.1016/j.fertnstert.2010.06.036. Epub 2010 Jul 23.

PMID:
20655529
10.

Polycystic ovary syndrome and the metabolic syndrome.

Weerakiet S.

J Med Assoc Thai. 2004 Oct;87 Suppl 3:S189-93.

PMID:
21213522
11.

The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.

Lee H, Oh JY, Sung YA, Chung H, Cho WY.

Endocrine. 2009 Oct;36(2):326-32. doi: 10.1007/s12020-009-9226-7. Epub 2009 Aug 14.

PMID:
19688613
12.

Effect of changes in waist circumference on metabolic syndrome over a 6.6-year follow-up in Tehran.

Hosseinpanah F, Barzin M, Mirmiran P, Azizi F.

Eur J Clin Nutr. 2010 Aug;64(8):879-86. doi: 10.1038/ejcn.2010.79. Epub 2010 May 19.

PMID:
20485305
13.

Is an appropriate cutoff of hypertriglyceridemic waist designated for type 2 diabetes among Chinese adults?

Yu D, Huang J, Hu D, Chen J, Cao J, Li J.

Clin Nutr. 2010 Apr;29(2):192-8. doi: 10.1016/j.clnu.2009.06.008. Epub 2010 Feb 12.

PMID:
20153095
14.

Abdominal obesity is associated with a lower ankle-brachial index in women with polycystic ovary syndrome.

Dogan MI, Tasci I, Bulucu F, Aydogdu A, Acar R, Ceyhan T, Koc B, Demir O, Gezer M, Saglam K.

Angiology. 2013 Feb;64(2):105-11. doi: 10.1177/0003319711436248. Epub 2012 Feb 21.

PMID:
22355193
15.

Pioglitazone reduces central obesity in polycystic ovary syndrome women.

Asadipooya K, Kalantar-Hormozi M, Nabipour I.

Gynecol Endocrinol. 2012 Jan;28(1):16-9. doi: 10.3109/09513590.2011.583958. Epub 2011 Jul 14.

PMID:
21756079
16.

Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome.

Gateva AT, Kamenov ZA.

Eur J Obstet Gynecol Reprod Biol. 2012 Oct;164(2):161-6. doi: 10.1016/j.ejogrb.2012.05.037. Epub 2012 Jun 23.

PMID:
22727921
17.

Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome.

Costa EC, Sá JC, Soares EM, Lemos TM, Maranhão TM, Azevedo GD.

Gynecol Endocrinol. 2012 Jan;28(1):12-5. doi: 10.3109/09513590.2011.583956. Epub 2011 Sep 29.

PMID:
21958393
18.

Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome.

Dabadghao P, Roberts BJ, Wang J, Davies MJ, Norman RJ.

Med J Aust. 2007 Sep 17;187(6):328-31.

PMID:
17874978
19.

High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome.

Chen MJ, Chen CD, Yang JH, Chen CL, Ho HN, Yang WS, Yang YS.

Hum Reprod. 2011 Jan;26(1):227-34. doi: 10.1093/humrep/deq308. Epub 2010 Nov 18.

PMID:
21088016
20.

Serum magnesium concentrations and metabolic variables in polycystic ovary syndrome.

Kauffman RP, Tullar PE, Nipp RD, Castracane VD.

Acta Obstet Gynecol Scand. 2011 May;90(5):452-8. doi: 10.1111/j.1600-0412.2010.01067.x. Epub 2011 Feb 3.

PMID:
21306320

Supplemental Content

Support Center